Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.
about
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Tumor-specific antivascular effect of TZT-1027 (Soblidotin) elucidated by magnetic resonance imaging and confocal laser scanning microscopy.Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxelThe novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivoVascular disrupting agents in clinical developmentPredictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Antitumor bioactive peptides isolated from marine organisms.Reference profiling of the genomic response induced by an antimicrotubule agent, TZT-1027 (Soblidotin), in vitro.Dose calculation of anticancer drugsEpothilones and new analogues of the microtubule modulators in taxane-resistant disease
P2860
Q26781365-9693E530-A407-4986-8525-05AFD3036043Q33272485-C4D4603B-DFA1-4204-B182-FAED6DD72D36Q33359943-8BD61A83-6879-4851-9B79-E291204E4178Q35012154-56FD5366-7CC8-4842-ACAF-91192BEF7DC5Q36609596-2019BA26-CCE0-4785-B0AC-EA041BA5F675Q36765436-C6EDC350-9BDF-48CD-8D02-7E2C92BDA8F5Q38047337-3089EB49-5BBB-43D7-B114-0663F52DFB75Q38663010-4247E5E8-AA15-4EC5-B8D7-17CB6D02ADEBQ40301795-808177A9-8FE5-4245-B439-5D87CDE6B286Q56391087-5816CA16-7E7F-48F0-AAA4-1B0D76263CE4Q57244875-EA310A06-97F3-4BB6-A28A-068C4A8FCEB3
P2860
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
type
label
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
prefLabel
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@ast
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
P2093
P1476
Phase I and pharmacokinetic st ...... ts with advanced solid tumors.
@en
P2093
Aletta Lems
André S T Planting
Ate van der Gaast
Jaap Verweij
Jantien Wanders
Leny van Doorn
Maja J A de Jonge
Masahiko Satomi
P304
P356
10.1158/1078-0432.CCR-04-1937
P407
P577
2005-05-01T00:00:00Z